Gene Logic Adds Lilly To Its Drug Rescue Roster
This article was originally published in The Pink Sheet Daily
Executive Summary
Company will reconsider drug candidates that were “discontinued or de-prioritized” for non-safety reasons and could even license them if Lilly opts out.